[1]
“PERILS AND DILEMMAS OF THE INDISCRIMINATE USE OF GLP‑1 AGONISTS FOR AESTHETIC WEIGHT LOSS”, REMUNOM, vol. 17, no. 1, pp. 1–9, Sep. 2025, doi: 10.61164/4bahhw68.